[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2016-2020 Japan Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs-Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

March 2016 | 590 pages | ID: 27CCF539D8AEN
Venture Planning Group

US$ 7,040.00 US$ 8,800.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. “2016 Japan Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains” is VPGMarketResearch’s new study of the major business opportunities emerging in the Japanese cancer diagnostics market during the next five years. The report examines trends in the Japanese market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.
I. INTRODUCTION

II. WORLDWIDE MARKET OVERVIEW

A. Market Overview
B. Worldwide Market Structure
C. Worldwide Market Size and Growth

III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products

IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

V. ALTERNATIVE MARKET PENETRATION STRATEGIES

VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

VII. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major Current and Emerging Cancer Diagnostic Tests
  1. Biochemical Tumor Markers
  2. Oncogenes
  3. Polypeptide Growth Factors
  4. Ectopic Hormones
  5. Colony Stimulating Factors
  6. Lymphokines
  7. Immunohistochemical Stains
  8. Emerging Tumor Markers
B. Instrumentation Review and Market Needs
C. Current and Emerging Technologies
D. Personal Testing

VIII. JAPAN

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
  Volume Forecasts by Test and Market Segment
  Sales Forecasts by Test and Market Segment
  Major Supplier Sales and Market Shares

IX. COMPETITIVE PROFILES

Abbott
AdnaGen
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
CellSearch
Cepheid
Correlogic Systems/Vermillion
Decode Genetics
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Elitech Group
Epigenomics
Enterix
Enzo Biochem
Exact Sciences
Fujirebio
Guided Therapeutics
Hologic/Gen-Probe
Kreatech/Leica
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen
Quest Diagnostics
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Thermo Fisher
Tosoh
Veridex
Wako Pure Chemicals
Wallac/PE
Zila

X. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING CANCER DIAGNOSTIC TECHNOLOGIES AND APPLICATIONS

LIST OF TABLES

Cancer Diagnostic Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta-2 Microglobulin Tests
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications In Cancer Diagnosis
Oncogenes Potential Applications In Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications In Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis
Executive Summary Table: Japan, Total Cancer Diagnostic Testing Volume and Sales Forecasts By Market Segment
Japan, Estimated Cancer Death Rates
Japan, Laboratories Performing Cancer Diagnostic Tests by Market Segment
Japan, Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
Japan, Commercial/Private Laboratories Performing Cancer Diagnostic Tests By Annual Test Volume
Japan, Total Cancer Diagnostic Testing Volume Forecasts by Market Segment
Japan, All Market Segments Major Cancer Diagnostic Test Volume Forecasts by Test
Japan, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts by Test
Japan, Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
Japan, Total Cancer Diagnostic Sales Forecasts by Market Segment
Japan, All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
Japan, Hospital Laboratories Major Cancer Diagnostic Sales Forecasts by Test
Japan, Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
Japan, ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, CA-125 Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Cathepsin Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Chromogranin Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecasts by Market Segment
Japan, Cytokeratins Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Interferons Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Interleukins Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Nucleolar Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Progesterone Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, S-100 Protein Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, TPA, Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Total Cancer Diagnostics Sales by Major Suppliers
Japan, AFP Testing Market Diagnostics Sales by Major Supplier
Japan, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
Japan, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
Japan, CA 125 Testing Market Diagnostics Sales by Major Supplier
Japan, Calcitonin Testing Market Diagnostics Sales by Major Supplier
Japan, PAP Testing Market Diagnostics Sales by Major Supplier
Japan, PSA Testing Market Diagnostics Sales by Major Supplier


More Publications